These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30010924)

  • 61. Silencing of
    Dainis A; Zaleta-Rivera K; Ribeiro A; Chang ACH; Shang C; Lan F; Burridge PW; Liu WR; Wu JC; Chang ACY; Pruitt BL; Wheeler M; Ashley E
    Physiol Genomics; 2020 Jul; 52(7):293-303. PubMed ID: 32567507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
    Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy.
    Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):664-665. PubMed ID: 33215320
    [No Abstract]   [Full Text] [Related]  

  • 64. CRISPR Craze to Transform Cardiac Biology.
    van Kampen SJ; van Rooij E
    Trends Mol Med; 2019 Sep; 25(9):791-802. PubMed ID: 31326354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modelling human calmodulinopathies with induced pluripotent stem cells: progress and challenges.
    Gomez-Hurtado N; Blackwell DJ; Knollmann BC
    Cardiovasc Res; 2017 Apr; 113(5):437-439. PubMed ID: 28384370
    [No Abstract]   [Full Text] [Related]  

  • 66. Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Oct; 64():102901. PubMed ID: 36037555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
    Higo S; Hikoso S; Miyagawa S; Sakata Y
    Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.
    Sysa-Shah P; Xu Y; Guo X; Belmonte F; Kang B; Bedja D; Pin S; Tsuchiya N; Gabrielson K
    PLoS One; 2012; 7(8):e42805. PubMed ID: 22912742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation.
    Dong Y; Li X; Fu W; Tian X; Guo G; Peng Y; Zhai Y; Zhao J; Ding Z; Zhao X; Dong J
    Stem Cell Res; 2022 Jan; 58():102622. PubMed ID: 34929444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy.
    Santini L; Palandri C; Nediani C; Cerbai E; Coppini R
    Pharmacol Res; 2020 Oct; 160():105176. PubMed ID: 32871247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CRISPR fixes disease gene in viable human embryos.
    Ledford H
    Nature; 2017 Aug; 548(7665):13-14. PubMed ID: 28770860
    [No Abstract]   [Full Text] [Related]  

  • 72. Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes.
    Josowitz R; Mulero-Navarro S; Rodriguez NA; Falce C; Cohen N; Ullian EM; Weiss LA; Rauen KA; Sobie EA; Gelb BD
    Stem Cell Reports; 2016 Sep; 7(3):355-369. PubMed ID: 27569062
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA.
    Dementyeva EV; Vyatkin YV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102348. PubMed ID: 33887580
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generation of a genetically-modified induced pluripotent stem cell line harboring a Noonan syndrome-associated gene variant MRAS p.G23V.
    Busley AV; Cyganek L
    Stem Cell Res; 2023 Jun; 69():103108. PubMed ID: 37141804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling.
    Jiang W; Lan F; Zhang H
    Curr Stem Cell Res Ther; 2016; 11(7):533-41. PubMed ID: 25322695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Proteomic Perspective on Cardiomyocyte Maturation.
    Muraoka N; Sun B; Murry CE
    Circ Res; 2019 Nov; 125(11):954-956. PubMed ID: 31697629
    [No Abstract]   [Full Text] [Related]  

  • 78. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy.
    Knight WE; Cao Y; Lin YH; Chi C; Bai B; Sparagna GC; Zhao Y; Du Y; Londono P; Reisz JA; Brown BC; Taylor MRG; Ambardekar AV; Cleveland JC; McKinsey TA; Jeong MY; Walker LA; Woulfe KC; D'Alessandro A; Chatfield KC; Xu H; Bristow MR; Buttrick PM; Song K
    Stem Cell Reports; 2021 Mar; 16(3):519-533. PubMed ID: 33636116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery.
    Zhao Y; Korolj A; Feric N; Radisic M
    Expert Opin Drug Saf; 2016 Nov; 15(11):1455-1458. PubMed ID: 27560951
    [No Abstract]   [Full Text] [Related]  

  • 80. Development of a Cardiac Sarcomere Functional Genomics Platform to Enable Scalable Interrogation of Human
    Pettinato AM; Ladha FA; Mellert DJ; Legere N; Cohn R; Romano R; Thakar K; Chen YS; Hinson JT
    Circulation; 2020 Dec; 142(23):2262-2275. PubMed ID: 33025817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.